Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALIVIZUMAB for Antiviral prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 3,080 adverse event reports in the FDA FAERS database where PALIVIZUMAB was used for Antiviral prophylaxis.

Most Reported Side Effects for PALIVIZUMAB

Side Effect Reports % Deaths Hosp.
Respiratory syncytial virus infection 1,692 14.8% 47 1,321
Pyrexia 1,055 9.2% 25 438
Death 856 7.5% 856 94
Bronchiolitis 724 6.3% 13 649
Cough 665 5.8% 9 351
Pneumonia 657 5.8% 55 579
Dyspnoea 466 4.1% 10 370
Nasopharyngitis 462 4.1% 4 206
Vomiting 445 3.9% 18 303
Influenza 398 3.5% 7 261
Product dose omission issue 381 3.3% 4 123
Covid-19 360 3.2% 4 172
Off label use 359 3.1% 26 166
Illness 346 3.0% 5 103
Nasal congestion 304 2.7% 3 102

Other Indications for PALIVIZUMAB

Premature baby (3,353) Product used for unknown indication (1,107) Respiratory syncytial virus infection (996) Bronchopulmonary dysplasia (827) Heart disease congenital (546) Low birth weight baby (399) Chronic respiratory disease (206) Lung disorder (186) Ventricular septal defect (177) Prophylaxis (140)

Other Drugs Used for Antiviral prophylaxis

VALGANCICLOVIR (1,515) VALACYCLOVIR (1,050) ACYCLOVIR (749) LETERMOVIR (574) GANCICLOVIR (463) OSELTAMIVIR (444) LAMIVUDINE (299) NIRSEVIMAB-ALIP (137) SULFAMETHOXAZOLE\TRIMETHOPRIM (123) INFLUENZA VIRUS VACCINE (116)

Related Pages

PALIVIZUMAB Full Profile All Antiviral prophylaxis Drugs PALIVIZUMAB Demographics PALIVIZUMAB Timeline